UKRAINIAN BULLETIN OF PSYCHONEUROLOGY

The Scientific and Practical Journal of Medicine
ISSN 2079-0325
DOI 10.36927/2079-0325

MULTIDIMENSIONAL ASSESSMENT OF CHRONIC PAIN: A STRATIFIED ANALYSIS BASED ON THE SPAASMS SCALE

Authors

Type of Article

In the Section

Index UDK:

Abstract

hronic pain is a multidimensional phenomenon shaped by sensory, affective, and behavioural components; however, in  routine clinical practice its assessment is  frequently limited to  unidimensional intensity scales. This constrains comprehensive evaluation of  the pain experience and  limits the  implementation of  personalised treatment strategies.

Objective. To  evaluate the  multidimensional structure of  subjective pain experience in  patients with different types of chronic pain using the SPAASMS scale, to identify between-group differences, and  to  assess the  impact of  sociodemographic factors on  the pain feeling.

A total of 302 adult outpatients with chronic pain lasting more than 3 months (after screening, n = 340) were examined. The study was conducted using a proactive psychiatric approach in accordance with ICD-10, taking into account the updated criteria of the ICD-11. Patients were stratified into five groups: primary psychogenic pain (PPP1), primary psychophysiological pain (PPP2), mixed primary psychogenic and psychophysiological pain (PPP3), secondary mixed pain (SMP), and secondary organic pain (SOP). Pain assessment was performed using the  SPAASMS scale. Statistical analysis included the  Kruskal–Wallis test, post hoc pairwise comparisons with Bonferroni correction, and Spearman correlation analysis (p  ≤  0.05).

Pain intensity measured by the visual analogue scale (VAS) did not differ significantly between groups (p  >0.05). In  contrast, all SPAASMS subscales demonstrated significant between-group differences (p < 0.001–0.01). The highest levels of subjective pain were observed in PPP1, PPP3, and  SMP groups, whereas the  lowest were found in  the SOP group (p  <  0.001). Physical functioning, sleep quality, and mood contributed most substantially to  the overall pain structure, while treatment-related side effects were minimal. Age  and financial status were significantly associated with subjective pain assessment, with effects varying across pain types.

The  SPAASMS scale enables identification of  distinct pain profiles depending on  pain type and sociodemographic context and may serve as a valuable tool for comprehensive assessment and  longitudinal monitoring of  treatment outcomes.

Pages

References

  1. Raja SN, Carr DB, Cohen M, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020 Sep 1;161(9):1976- 1982. doi:10.1097/j.pain.0000000000001939
  2. Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the  IASP Classification of  Chronic Pain for the International Classification of Diseases (ICD 11). Pain. 2019 Jan; 160(1):19-27. doi:10.1097/j.pain.0000000000001384
  3. Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. The Lancet. 2021; 397(10289):2082-2097. doi:10.1016/S0140-6736(21)00393-7
  4. GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023 May 22;5(6): e316-e329. doi:10.1016/S2665-9913(23)00098-X
  5. World Health Organization. Low back pain. Fact sheet. 2023. https://www.who.int/news-room/fact-sheets/detail/lowback-pain?utm_source=chatgpt.com
  6. Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019 Aug;123(2): e273-e283. doi:10.1016/j.bja.2019.03.023
  7. Asanova A. [Pain and Disability: Indirect Assessment of Quality of Life Using the WHODAS 2.0 Scale in Patients with Chronic Pain]. PMGP. 09 June 2025;10(2).10.26766/pmgp.v10i2.619. (In Ukrainian).
  8. Kosek E, Clauw D, Nijs J, et al. Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain. 2021 Nov 1;162(11): 2629-2634. doi:10.1097/j.pain.0000000000002324
  9. Nijs J, Lahousse A, Kapreli E, et al. Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future. J Clin Med. 2021 Jul 21;10(15): 3203. doi:10.3390/jcm10153203
  10. Aaron RV, Ravyts SG, Carnahan ND, et al. Prevalence of Depression and Anxiety Among Adults With Chronic Pain: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2025;8(3): e250268. doi:10.1001/jamanetworkopen.2025.0268
  11. Santos M, Gabani FL, de Andrade SM, et al. The bidirectional association between chronic musculoskeletal pain and sleep-related problems: a systematic review and metaanalysis. Rheumatology (Oxford). 2023 Sep 1;62(9): 2951-2962. doi:10.1093/rheumatology/kead190
  12. Runge N, Ahmed I, Saueressig T, et al. The bidirectional relationship between sleep problems and chronic musculoskeletal pain: a systematic review with meta-analysis. Pain. 2024 Nov 1;165(11):2455-2467. doi:10.1097/j.pain.0000000000003279
  13. Kapos FP, Craig KD, Anderson SR et al. Social Determinants and Consequences of Pain: Toward Multilevel, Intersectional, and Life Course Perspectives. The Journal of Pain. 2024 Oct;25(10): 104608. doi:10.1016/j.jpain.2024.104608
  14. Nicholas, Michael K. The biopsychosocial model of pain 40 years on: time for a reappraisal? Pain. 2022;163(S1):S3-S14, November 2022. doi:10.1097/j.pain.0000000000002654
  15. Stretanski MF, Stinocher S, Grandhe S. Pain Assessment. [Updated 2025 Jun 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK556098/?utm_source=chatgpt.com
  16. Nugent SM, Lovejoy TI, Shull S, et al. Associations of Pain Numeric Rating Scale Scores Collected during Usual Care with Research Administered Patient Reported Pain Outcomes. Pain Med. 2021 Oct 8;22(10): 2235-2241. https://doi.org/10.1093/pm/pnab110
  17. Alebouyeh F, Boutron I, Ravaud P, et al. Psychometric properties and domains covered by patient-reported outcome measures used in trials assessing interventions for chronic pain. J Clin Epidemiol. 2024 Jun; 170:111362. doi:10.1016/j.jclinepi.2024.111362
  18. Mitra F, Chowdhury S, Shelley M, et al. Measuring Clinical Outcomes of Chronic Pain Patients. Pract Pain Manag. 2011;11(1). https://www.medcentral.com/pain/chronic/measuring-clinical-outcomes-chronic-pain-patients
  19. Chaban O. S., Khaustova O. O, Asanova A. E. Praktična psihosomatika: dìagnostičnì škali [Practical psychoso-matics: diagnostic scales]; eds. O. S. Chaban, O. O. Khaustova. 4th ed., revi sed and expanded. Kyiv: Medkniga, 2025. 248 p. (In Ukrainian).
  20. Vase L, Wager TD, Eccleston C. Opportunities for chronic pain self-management: core psychological principles and neurobiological underpinnings. Lancet. 2025 May 17;405(10491): 1781-1790. doi:10.1016/S0140-6736(25)00404-0
  21. Bäckryd E, Persson EB, Larsson AI, et al. Chronic pain patients can be classified into four groups: Clustering-based discriminant analysis of psychometric data from 4665 patients referred to a multidisciplinary pain centre (a  SQRP study). Plos One. 2018; 13(2):e0192623. doi:10.1371/journal.pone.0192623
  22. Asanova A. Psihoemocìjnì determìnanti agresìï ta  vorožostì u  pacìêntìv ìz  hronìčnim bolem [Psychoemotional determinants of aggression and hostility in patients with chronic pain. Ukraïns'kij vìsnik psihonevrologìï [Ukrainian Bulletin of Psycho-neurology]. 2025;33(4):92-100.10.36927/2079-0325-V33-is4-2025-12. (In Ukrainian).
  23. Whale K, Gooberman-Hill R. The Importance of Sleep for People With Chronic Pain: Current Insights and Evidence. JBMR Plus. 2022 Jun 17;6(7):e10658. doi:10.1002/jbm4.10658
  24. Bloomberg M, Bu F, Fancourt D, Steptoe A. Demographic and socioeconomic risk factors for pain progression and recurrence in middle-aged and older adults: multistate analysis of  a  prospective English cohort study. Age Ageing. 2026 Jan 3;55(1): afaf364. doi:10.1093/ageing/afaf364